{"name":"Cochlear","slug":"cochlear","ticker":"COH","exchange":"ASX","domain":"cochlear.com","description":"Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.","hq":"Sydney, Australia","founded":1982,"employees":"5500","ceo":"Dig Howitt","sector":"Hearing Implants / Medical Devices","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":95.42,"stockChange":-4.64,"stockChangePercent":-4.64,"marketCap":"$4.5B","metrics":{"revenue":1690400602.654249,"revenueGrowth":-0.4,"grossMargin":72.8,"rdSpend":0,"netIncome":249602439.228,"cash":135246499.796,"dividendYield":4.51,"peRatio":18.1,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Cochlear Limited Reports Strong Half-Year Results","summary":"Cochlear Limited reported strong half-year results, with revenue up 12% and net profit up 15%.","drugName":"","sentiment":"positive"},{"date":"2023-11-30","type":"deal","headline":"Cochlear Limited Acquires Otology and Neurotology Business","summary":"Cochlear Limited has acquired the otology and neurotology business of Otology and Neurotology, Inc.","drugName":"","sentiment":"positive"},{"date":"2023-08-24","type":"regulatory","headline":"Cochlear Limited Receives FDA Approval for Nucleus 8 Sound Processor","summary":"Cochlear Limited has received FDA approval for its Nucleus 8 Sound Processor.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPdW9zZTVyZWw0akVCQ0dZSi14MjRYT3lXUXhzc2RHZlJHUHFtS2FSUGp2OURncTJGTUR0Ni1XaTkzWERGWldpQ2dSMDNRSl9DRS1IcnZ5XzNXMEJ3QW1UTUp4TnBWTWRpUDNwWWtUbVlDYVZhaEJsNjktSEpQU1h5WFFnMmhRTWNYbzNyamhWalMzZ2tlUFVNTy1HZHZsS3RLaDJlM2dNYjNRc3R0bXlNUkdUWVBqd1RhSlFSMWxVaw?oc=5","date":"2026-03-16","type":"deal","source":"AD HOC NEWS","summary":"Cochlear Ltd Stock (ISIN: AU000000COH5) Hits Multi-Year Lows as Brokers Flag Compelling Buy Opportun - AD HOC NEWS","headline":"Cochlear Ltd Stock (ISIN: AU000000COH5) Hits Multi-Year Lows as Brokers Flag Compelling Buy Opportun","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQc3gwc29aNnExUVBBZzlzSHNiS2VmOVhiSTF2TEV0LW9nQm1Db1dReEEzc3gtYUZxQkcxbU1NYVV4eTJVc2lRdy0zSFVER2hJVGhtOEdlSWRWcTJFWHdiQ3VVaVJQQUMzaTZWM2Z3akVMZGNXNTN4c09zU3dPN2UwcFlnTU0xNWZoQ1pib2JCa1BqMFZuUlNIS09xSk5LeTE0Y2laWk0zUDdPUVE?oc=5","date":"2026-03-16","type":"pipeline","source":"Kalkine Media","summary":"Cochlear (ASX:COH) Gains Attention Across ASX 50 on Implant Tech - Kalkine Media","headline":"Cochlear (ASX:COH) Gains Attention Across ASX 50 on Implant Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNUXN6UDhkdFl6bU5SWWNNSzRxanJqYTg1WFpYbnhXMXoxVWlzN0NkWTBkNjJiSkFRRkhvTTIwc1k0dWlzMFp6cWJQMVdSZGgyUVl0ei1Mb0xZSzlLVW1fclo4VDc4Zjd2N1g2UlU0YmE4MDVfSURsWHVQTVdETEtVYkxZdEZHdDFXeHVNMlE3TQ?oc=5","date":"2026-03-11","type":"pipeline","source":"The Motley Fool Australia","summary":"Four ASX healthcare stocks which are looking cheap - The Motley Fool Australia","headline":"Four ASX healthcare stocks which are looking cheap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSUV2bmZJWEVoMFZvcEdaYWk0QXA3cEdiWDBVaENnbmFPN0Q5Z1V0RGFqOHpfNUVCR19sTEx5QnhFeEx4QkFabTRPNFBQTVJMLUgwSmNiUGdRMFE0cUFpRkJlQXFCU0VjanJjUURpNkdiaURGd1ZVRXlOdlU4M3VkUjVmUE95YllSTjNtUllONk9vb1Z5LUFHd2pzOW84NHBTUGxwNXhxTDR0RlRNTGo1eFJURGcxWHZH?oc=5","date":"2026-02-27","type":"pipeline","source":"Stockhead","summary":"Biocurious: Healthcare leaders given the cold shoulder amid a lovelorn reporting season - Stockhead","headline":"Biocurious: Healthcare leaders given the cold shoulder amid a lovelorn reporting season","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOOEpTSVpsb1M1X05IeU96UXVGQ2hSZHVabl9IMFBNYkt0LVdEbWlHZ2loQWFaUEl3cl9pZXZXblViLXpiZkYyTl9BZ0Z4Q0E4X0RrN0FmU0stSFY0RVQ4N2V6dU01NUl2dXByVkFVQTV5UFBTeE1SVlV1Ujcydlp4WEVXUWF2N193UTlGNW1XVEtqMFpxSG93bHgxaHd4Q250SGlWd1d3?oc=5","date":"2026-02-16","type":"pipeline","source":"Market Index","summary":"ChartWatch ASX Scans: Cochlear, CSL, Pro Medicus, Telix Pharmaceuticals, Technology One, Rio Tinto - Market Index","headline":"ChartWatch ASX Scans: Cochlear, CSL, Pro Medicus, Telix Pharmaceuticals, Technology One, Rio Tinto","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPWkJ5S0VjUlRldXhfZlJTMmJxaXdsVEpjbWRHSDJ6TmRmUFV5ZjNGQXFtMm5IenZkcTFocFNoYlUwcGtrSlRaRnVYTlU4Sm9JckpXdGVCVW1SVDJZQTlnSE5iaGJqVzVMd2IzVktFRDZXTkxYMjlyVXVGaXZvektLZnhCTXpheHJGT1UwTW5MdWJDYTNhT0Y4dzlqME5obWdJWEMwTmt0bUR3MG9uNFEw?oc=5","date":"2026-02-13","type":"pipeline","source":"Stockhead","summary":"Closing Bell: Tech brutalised as the ASX scrambles for safety on Friday the 13th - Stockhead","headline":"Closing Bell: Tech brutalised as the ASX scrambles for safety on Friday the 13th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPR0xXQVFabkxUMkdfbDdHWUVHZUhlSnJkaHYzWGg2UTBfWXRxOXU1ZTRkM1pYbWtkSWpMdXNWUzVObTRoMTNlT3VMcTdQQjZCZlVZQmdSM2x4WURueDZkTGZsNDZwR1hGX2NXdVRPRHhqdmstRjFUUUV2MTUyV3ZGRXRDek1wWlZvTEliNzk3dlBDeE54R2p6OTdmSHd1ZkJOX1hBUHRGLUM5ZnBXcTg3LUZ5YnBIN0JYS3dfazFmd0tOdk52Ui1XSnltOWxDdnM?oc=5","date":"2026-01-08","type":"pipeline","source":"PR Newswire","summary":"Cochlear Announces Availability of Nucleus Nexa System to US Military Veterans - PR Newswire","headline":"Cochlear Announces Availability of Nucleus Nexa System to US Military Veterans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxObDEwcVpXSXNwNTBTZFdyWnBmSmtOdEE5Q0VlYmNQOEYxNFk4OHQwS015SFZXVV9CZC1MNnRuUVJQaXY5ejRsZzJBRl9ucXpvamtIY1p3dl9TaFRLZ0g3TzRCV1dMOW5wMVU1amZ1Sk41blZScW5NY3BHM2ZmS2tSa3NXVUdidEFoWk5QdmtjTFF6dXpoc1pNSVViTFFaQWR3SmFWR2pxUmNPRm1TbHE3SHpuYWVESk9JaE15TW1MeXNQdWZNVDFZeVNlUFFYYkdpMEhuSTFR?oc=5","date":"2025-12-03","type":"pipeline","source":"Business News Australia","summary":"Cochlear-backed epilepsy medtech Epiminder’s shares on the slide after $125m public offer - Business News Australia","headline":"Cochlear-backed epilepsy medtech Epiminder’s shares on the slide after $125m public offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNMmt6aDhHS19Cc2FseHRqM2ZHY1c5TU1tUXpXTHhFY1MzTGlsaVFhRGtMTUsySDZCclVqUW5sMXYxMjUyNGk2UExtZ0Z4Xy1PMHQtc0VmbHVVZ1dnMG04TUNDYUFqdTFFRDhrVVVUZGlPaXhOcnkxTGRZelZkU01lcElxdUtCTmRqZFhKVURGbVN3VEpfRG42aG1NMlZTUQ?oc=5","date":"2025-10-15","type":"pipeline","source":"Kalkine Media","summary":"Cochlear (ASX:COH) Shares: 6 Must-Know Investor Metrics - Kalkine Media","headline":"Cochlear (ASX:COH) Shares: 6 Must-Know Investor Metrics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPUTVvNDVya21nWTloeE56bWllOEstMllFZ0hpWFhXZkNWd0J4LWVCdGN0RjR4bnNqSVRFaXlvTFRLZTlMTzJRd1NjanVpd0ptT2gyd2doVkl0MTAyVW8tYnVRbGlqb1NqV1lhcmtrV0h3NVdYOXlFcFEyWWQ4RFM5QUlDT2U5Qmx6UXU0RU1Fa0d6aVZubVM0?oc=5","date":"2025-09-26","type":"pipeline","source":"Sharecafe","summary":"Trump’s pharma tariff move drags health stocks lower - Sharecafe","headline":"Trump’s pharma tariff move drags health stocks lower","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOR0lOZEdxZ0N2SUEtWExiQnd4YUx5R25GYzR0NUtKaWdvR3FIQmlpclpmWkdhRlpGVXpIX2ZRcV8zR2pKWVlyc0ppVFhjRERMem04X2dYSmo1eXhUQUJuLTFCbWwzVWtoTDVCQ2IyaEhOY0FLSWZRUFhjcUk0OW5sdUdyQldBRzJJLThjTURBYkwwRFVVZjZJeEIwTzZ2QQ?oc=5","date":"2025-09-23","type":"pipeline","source":"ig.com","summary":"ASX 200 healthcare stocks: ResMed, CSL, and Telix Pharmaceuticals in focus - ig.com","headline":"ASX 200 healthcare stocks: ResMed, CSL, and Telix Pharmaceuticals in focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9WVlF2c0loT3pJbjQyMDh5N2tFUUpIRlJvQ1hJeHd6bVg1NmRhUGRjd3ZMcGpDY1RiLV9iaTFjUTJYSVg3WWtCZEZfU3NkQV9jRUVUem5Ec3M3ZGlBQUduc1hFVUdXajE3NlR5X01zLVZWNEJtY08wblpRMUc?oc=5","date":"2025-07-17","type":"pipeline","source":"Stocks Down Under","summary":"How Trump’s Proposed 200% Tariffs Could Hit CSL (ASX:CSL) and Other Aussie Biotechs - Stocks Down Under","headline":"How Trump’s Proposed 200% Tariffs Could Hit CSL (ASX:CSL) and Other Aussie Biotechs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":4,"keyCompetitors":["Oticon Medical","Advanced Bionics","MED-EL"],"therapeuticFocus":["Hearing Loss","Deafness"],"financials":{"source":"yahoo_finance","revenue":1693725674.356,"revenuePeriod":"2025-06-30","revenueHistory":[{"period":"2025-06-30","value":1693725674.356},{"period":"2024-06-30","value":1616018572.656},{"period":"2023-06-30","value":1399522973.036},{"period":"2022-06-30","value":1191484797.508}],"grossProfit":1249024195.604,"grossProfitHistory":[{"period":"2025-06-30","value":1249024195.604},{"period":"2024-06-30","value":1209700787.86},{"period":"2023-06-30","value":1046768874.156},{"period":"2022-06-30","value":894390669.148}],"rdSpend":210712745.54,"rdSpendHistory":[{"period":"2025-06-30","value":210712745.54},{"period":"2024-06-30","value":200231322.52},{"period":"2023-06-30","value":177027620.524},{"period":"2022-06-30","value":152305919.332}],"sgaSpend":679413068.724,"operatingIncome":293552130.236,"operatingIncomeHistory":[{"period":"2025-06-30","value":293552130.236},{"period":"2024-06-30","value":299262698.64},{"period":"2023-06-30","value":225459023.444},{"period":"2022-06-30","value":213893315.284}],"netIncome":281118993.964,"netIncomeHistory":[{"period":"2025-06-30","value":281118993.964},{"period":"2024-06-30","value":257915291.968},{"period":"2023-06-30","value":217290742.056},{"period":"2022-06-30","value":208977889.31599998}],"eps":5.943,"epsHistory":[{"period":"2025-06-30","value":5.943},{"period":"2024-06-30","value":5.43},{"period":"2023-06-30","value":4.561},{"period":"2022-06-30","value":4.396}],"cash":199291608.732,"cashHistory":[{"period":"2025-06-30","value":199291608.732},{"period":"2024-06-30","value":371259231.936},{"period":"2023-06-30","value":401546930.18},{"period":"2022-06-30","value":454893759.068}],"totalAssets":2042070347,"totalLiabilities":632282807.972,"totalDebt":170377338.332,"equity":1409787539.0279999,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":-74165103.576,"capexHistory":[{"period":"2025-06-30","value":-74165103.576},{"period":"2024-06-30","value":-64912537.048},{"period":"2023-06-30","value":-69321963.284},{"period":"2022-06-30","value":-55804541.872}],"freeCashflow":97585662.6,"dividendsPaid":-201098750.632,"buybacks":-20456846.308,"employees":5500,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":95.42,"previousClose":100.06,"fiftyTwoWeekHigh":319.56,"fiftyTwoWeekLow":88.74,"fiftyTwoWeekRange":"88.74 - 319.56","fiftyDayAverage":146.92,"twoHundredDayAverage":240.87,"beta":0.24,"enterpriseValue":4771441598.820537,"forwardPE":18.4,"priceToBook":3.22,"priceToSales":2.67,"enterpriseToRevenue":2.82,"enterpriseToEbitda":11.74,"pegRatio":0,"ebitda":406245499.12,"ebitdaMargin":24,"freeCashflow":75231317.297,"operatingCashflow":191195613.02,"totalDebt":175075907.27199998,"debtToEquity":12.5,"currentRatio":2.46,"returnOnAssets":11.3,"returnOnEquity":18.1,"analystRating":"2.4 - Buy","recommendationKey":"buy","numberOfAnalysts":15,"targetMeanPrice":126.08,"targetHighPrice":170,"targetLowPrice":95,"dividendRate":4.3,"payoutRatio":0.82,"fiveYearAvgDividendYield":1.36,"exDividendDate":1773878400,"insiderHeldPercent":0.6,"institutionHeldPercent":52.4,"sharesOutstanding":65398917,"floatShares":65154888,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":5.28,"epsForward":5.2,"revenuePerShare":35.75,"bookValue":29.63,"officers":[{"age":58,"name":"Mr. Diggory William Howitt BE (Hons), MBA","title":"CEO, MD, President & Executive Director"},{"age":null,"name":"Dr. Sarah  Thom","title":"Chief Financial Officer"},{"age":60,"name":"Mr. Jan  Janssen MSc Elec Eng","title":"Chief Technology Officer"},{"age":null,"name":"Mr. Stuart  Sayers","title":"President of Asia Pacific & Latin America"},{"age":null,"name":"Ms. Karen  O'Driscoll","title":"Chief Information Officer"},{"age":null,"name":"Ms. Kristina  Devon","title":"VP of Corporate Strategy & Investor Relations"},{"age":null,"name":"Mr. Rob  McGrory","title":"Group General Counsel & Company Secretary"},{"age":null,"name":"Ms. Jennifer  Stevenson","title":"VP of Corporate Communications & Brand"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.cochlear.com","phone":"61 2 9428 6555"}}